Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in

[1]  J. Tchinda,et al.  Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.

[2]  J. Baselga,et al.  Impact of Genomics on Personalized Cancer Medicine , 2012, Clinical Cancer Research.

[3]  P. Nelson,et al.  Integrative molecular profiling of routine clinical prostate cancer specimens. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  Levi A Garraway,et al.  Precision oncology: an overview. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Ashish Choudhary,et al.  Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. , 2013, The Journal of molecular diagnostics : JMD.

[6]  Stephen J. Salipante,et al.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers , 2011, Proceedings of the National Academy of Sciences.

[7]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[8]  David R Parkinson,et al.  Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics , 2012, Clinical Cancer Research.

[9]  Alex M. Fichtenholtz,et al.  Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing , 2013, Nature Biotechnology.

[10]  S. Tomlins,et al.  The prostate cancer genome: perspectives and potential. , 2014, Urologic oncology.

[11]  J. Mendelsohn.  Personalizing oncology: perspectives and prospects. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[13]  Michael Ittmann,et al.  Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. , 2006, Cancer research.

[14]  Arul M Chinnaiyan,et al.  Common gene rearrangements in prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Derek Y. Chiang,et al.  Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.

[16]  J. T. Jørgensen,et al.  Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects , 2014, Front. Oncol..

[17]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[18]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[19]  C. Liang,et al.  Pathogenesis of prostatic small cell carcinoma involves the inactivation of the P53 pathway. , 2012, Endocrine-related cancer.

[20]  A. Hauschild,et al.  Improved overall survival in melanoma with combined dabrafenib and trametinib. , 2015, The New England journal of medicine.

[21]  Andreas Heger,et al.  Next-generation Sequencing of Advanced Prostate Cancer Treated with Androgen-deprivation Therapy , 2014, European urology.

[22]  Somasekar Seshagiri,et al.  Somatic mutations lead to an oncogenic deletion of met in lung cancer. , 2006, Cancer research.

[23]  Nickolay A. Khazanov,et al.  430 Analysis of 2,700 Cancer Exomes to Identify Novel Cancer Drivers and Therapeutic Opportunities , 2012 .

[24]  M. Rubin,et al.  New Strategies in Prostate Cancer: Translating Genomics into the Clinic , 2012, Clinical Cancer Research.

[25]  S. Tomlins,et al.  Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinoma , 2015, Virchows Archiv.

[26]  Adam Kiezun,et al.  Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine , 2013, Nature Medicine.

[27]  A. Iafrate,et al.  Anchored multiplex PCR for targeted next-generation sequencing , 2014, Nature Medicine.

[28]  J. Utikal,et al.  Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. , 2014, The New England journal of medicine.

[29]  M. Rubin,et al.  Aggressive Variants of Castration-Resistant Prostate Cancer , 2014, Clinical Cancer Research.

[30]  A. Sivachenko,et al.  Punctuated Evolution of Prostate Cancer Genomes , 2013, Cell.

[31]  Benjamin J. Raphael,et al.  The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2016 .

[32]  Kathleen R. Cho,et al.  HRAS mutations are frequent in inverted urothelial neoplasms. , 2014, Human pathology.

[33]  Stephen Moore,et al.  Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. , 2015, The Journal of molecular diagnostics : JMD.

[34]  M. Rubin,et al.  Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. , 2013, European urology.

[35]  J. Trapman,et al.  ETS fusion genes in prostate cancer. , 2014, Endocrine-related cancer.

[36]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[37]  B. Druker,et al.  Translation of the Philadelphia chromosome into therapy for CML. , 2008, Blood.

[38]  Edwin Cuppen,et al.  Simultaneous detection of clinically relevant mutations and amplifications for routine cancer pathology. , 2015, The Journal of molecular diagnostics : JMD.

[39]  C. Vogel,et al.  Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. , 2005, Clinical breast cancer.

[40]  Jun Luo,et al.  Decoding the androgen receptor splice variants , 2013, Translational andrology and urology.

[41]  J. Leamon,et al.  Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping. , 2013, The Journal of molecular diagnostics : JMD.

[42]  Francesca Demichelis,et al.  Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma , 2010, Nature Medicine.

[43]  Russell Weiner,et al.  Navigating the Rapids: The Development of Regulated Next-Generation Sequencing-Based Clinical Trial Assays and Companion Diagnostics , 2014, Front. Oncol..

[44]  Paul D. Williams,et al.  Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors , 2015, Molecular Cancer Research.

[45]  William Pao,et al.  Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. , 2014, JAMA.

[46]  J. Datta,et al.  Comparison of custom capture for targeted next-generation DNA sequencing. , 2015, The Journal of molecular diagnostics : JMD.

[47]  Lee T. Sam,et al.  Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study , 2011, Science Translational Medicine.

[48]  M. Emi,et al.  Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma , 1999, Genes, chromosomes & cancer.

[49]  Rashmi Kanagal-Shamanna,et al.  Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. , 2013, The Journal of molecular diagnostics : JMD.

[50]  P. Nelson,et al.  The androgen/androgen receptor axis in prostate cancer , 2012, Current opinion in oncology.

[51]  S. Tomlins.  Molecular Clues Assist in the Cancer Clinic , 2013, Science Translational Medicine.

[52]  Eric W. Klee,et al.  Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma , 2014, PLoS genetics.

[53]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[54]  Michael R Stratton,et al.  Genomics and the continuum of cancer care. , 2011, The New England journal of medicine.

[55]  W. Isaacs,et al.  AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer. , 2014, The New England journal of medicine.

[56]  A. Eychène,et al.  Alternative Splicing in Oncogenic Kinases: From Physiological Functions to Cancer , 2011, Journal of nucleic acids.